Natera, Inc., a global leader in cell-free DNA testing, announced the results of a large, real-world study confirming strong performance of its Prospera donor-derived...
Cambrian Biopharma, a multi-asset longevity biotech, announced a licensing agreement with Novartis to advance novel, selective compounds designed and characterized by Novartis to target...
Curve Therapeutics (Curve), a private biotechnology company pioneering a potentially game-changing, functional drug discovery platform, announces a global research collaboration with MSD, the trade...
